Loading
companiesCompany
ABX advanced biochemical compounds
ABX is a German maker of the precursors and kits behind PET imaging tracers, including PSMA agents for prostate cancer, and sponsors the trials that register them.
Also called: ABX advanced biochemical compounds GmbHABX GmbHABX
Overview
ABX advanced biochemical compounds, based in Radeberg near Dresden, manufactures radiopharmaceutical precursors, cold kits and labelling chemistry used to produce PET tracers, among them PSMA-directed agents for prostate cancer imaging developed with the German Cancer Research Center. It acts as lead sponsor of phase 3 diagnostic trials registered on ClinicalTrials.gov.
Headquarters
Radeberg, DE
Scorecard
All companies#367of 1244 companies, score 10
- phase 3 +3
- targets +2
- modalities +2
- registry trials +3
0 approved, 1 in phase 3, 0 earlier, 1 targets, 2 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
Phase 3PSMA-targeted PET radiotracer, fluorine-18
PSMA-1007 is a fluorine-18 PSMA PET tracer from ABX in Germany, widely used in Europe for prostate cancer staging because little of it reaches the bladder, and in a phase 3 trial registered by its maker.
Similar pages
- CompanyForesee Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Prostate cancer.
- CompanyOakwood Laboratories
Shares Pivotal (registrational) trial, Clinical trial, Prostate cancer.
- CompanyIonis Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Prostate cancer.
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
cancers
technologies
drugs
Phase 3PSMA-targeted PET radiotracer, fluorine-18